Preventing cancer and reducing cancer morbidity and mortality are the unifying long-range goals of the Cancer Control and Population Sciences (CCPS) Program. This Program's shared vision is to generate outstanding science that improves cancer prevention and care through bold discovery and applications. Investigative work is within two broad areas: cancer genetics and epidemiology and behavioral and outcomes research. Research in both thematic areas aims at identifying efficient intervention targets and effective intervention techniques, including individualized and patient-centric approaches along the cancer control continuum. The following are key areas of programmatic strength and depth: ? Genetic risk prediction and gene localization/discovery ? The study of gene-environment interactions ? Development and testing of models for translation of discoveries into interventions, with the goal of assuring quality implementation and broad access The CCPS Program has made considerable progress in addressing its scientific and programmatic goals during the previous five years. Recent major scientific discoveries include 1) localization and discovery of predisposing genes for prostate cancer and melanoma, 2) seminal work on the role of gene-environment interactions involving inflammatory and metabolic pathways in breast and colorectal cancer etiology, and 3) characterization of behavioral and psychosocial outcomes of genetic risk communication interventions for hereditary breast and ovarian cancer and for melanoma. Led by Anita Kinney, PhD, RN, the CCPS Program includes 32 members from five schools/colleges and 12 departments. Between July 2003 and March 2009, this highly productive and collaborative group generated 443 cancer-relevant publications, of which 25% were intra- and 20% were inter-programmatic collaborations. Program direct cost peer-reviewed funding in 2008 was $11M, including $7.3M in NCI funding. The synergistic relationship between the Cancer Center and the CCPS Program is highly beneficial to both groups. CCPS members provide methodological expertise in both basic and applied research and participate in translational research activities that bridge basic discoveries with clinical and population applications. The Cancer Center provides appropriate supportive funding, access to Shared Resources and other Center facilities, facilitation of transdisciplinary collaborations, and funding for faculty recruitments. Over the next five years, CCPS anticipates facilitating more individualized approaches to cancer prevention and treatment through relevant research findings. In addition, CCPS foresees its research in prevention and control will lead to new discoveries aimed at reducing cancer disparities among underserved populations, including American Indian, Hispanic/Latino, elderiy, and rural peoples.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-24
Application #
8465115
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
24
Fiscal Year
2013
Total Cost
$37,832
Indirect Cost
$21,836
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Himbert, Caroline; Ose, Jennifer; Nattenmüller, Johanna et al. (2018) Body fatness, adipose tissue compartments and biomarkers of inflammation and angiogenesis in colorectal cancer: the ColoCare Study. Cancer Epidemiol Biomarkers Prev :
Zeng, Tao; Fleming, Aaron M; Ding, Yun et al. (2018) Nanopore Analysis of the 5-Guanidinohydantoin to Iminoallantoin Isomerization in Duplex DNA. J Org Chem 83:3973-3978
Arbeeva, Liubov S; Hanson, Heidi A; Arbeev, Konstantin G et al. (2018) How Well Does the Family Longevity Selection Score Work: A Validation Test Using the Utah Population Database. Front Public Health 6:277
Madison, Bethany J; Clark, Kathleen A; Bhachech, Niraja et al. (2018) Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites. J Biol Chem 293:18624-18635
De, Shrutokirti; Van Deren, Donn; Peden, Eric et al. (2018) Two distinct ontogenies confer heterogeneity to mouse brain microglia. Development 145:
Patel, Ami B; Lange, Thoralf; Pomicter, Anthony D et al. (2018) Similar expression profiles in CD34+ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib. Oncotarget 9:17889-17894
Doherty, Jennifer A; Grieshober, Laurie; Houck, John R et al. (2018) Telomere Length and Lung Cancer Mortality among Heavy Smokers. Cancer Epidemiol Biomarkers Prev 27:829-837
Giraddi, Rajshekhar R; Chung, Chi-Yeh; Heinz, Richard E et al. (2018) Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland Development. Cell Rep 24:1653-1666.e7
Kleinstern, Geffen; Camp, Nicola J; Goldin, Lynn R et al. (2018) Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. Blood 131:2541-2551
Wagner, Alex H; Devarakonda, Siddhartha; Skidmore, Zachary L et al. (2018) Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer. Nat Commun 9:3787

Showing the most recent 10 out of 1193 publications